Page last updated: 2024-11-01

o(6)-benzylguanine and Ovarian Neoplasms

o(6)-benzylguanine has been researched along with Ovarian Neoplasms in 1 studies

O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research Excerpts

ExcerptRelevanceReference
"In the human ovarian cancer lines SK-OV-3 and OAW 42, O6-AGT activity was 337."1.29Inhibition of O6-alkylguanine-DNA alkyltransferase in animal and human ovarian tumor cell lines by O6-benzylguanine and sensitization to BCNU. ( Magull-Seltenreich, A; Zeller, WJ, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Magull-Seltenreich, A1
Zeller, WJ1

Other Studies

1 other study available for o(6)-benzylguanine and Ovarian Neoplasms

ArticleYear
Inhibition of O6-alkylguanine-DNA alkyltransferase in animal and human ovarian tumor cell lines by O6-benzylguanine and sensitization to BCNU.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cystadenocarcinoma,

1995